7-151786519-G-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM2BP6BS1BS2
The NM_016203.4(PRKAG2):c.137C>A(p.Pro46Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,460,626 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P46L) has been classified as Uncertain significance.
Frequency
Consequence
NM_016203.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- PRKAG2-related cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- lethal congenital glycogen storage disease of heartInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Wolff-Parkinson-White syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKAG2 | NM_016203.4 | c.137C>A | p.Pro46Gln | missense_variant | Exon 2 of 16 | ENST00000287878.9 | NP_057287.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 248502 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460626Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726420 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:2
The c.137C>A (p.P46Q) alteration is located in exon 2 (coding exon 2) of the PRKAG2 gene. This alteration results from a C to A substitution at nucleotide position 137, causing the proline (P) at amino acid position 46 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
PM2 -
Cardiomyopathy Uncertain:1
Variant of Uncertain Significance due to insufficient evidence: This missense variant replaces proline with glutamine at codon 46 of the PRKAG2 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant nor has this variant been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 4/243368 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the pathogenicity of this variant conclusively. -
Lethal congenital glycogen storage disease of heart Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at